Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzheng Huayu Tablets in Posthepatitic Cirrhosis
NCT00543426Phase 4Completed
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Sep 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Liver cirrhosis (LC) comparing Fuzheng Huayu with Placebo (2 arms). Primary endpoints: Child-Pugh Score at 6 months and Symptoms Scale for Posthepatitic Cirrhosis at 6 months. Started Sep 2007; status: completed.
02
Drugs
fuzheng huayu
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT00543426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543426.